314 related articles for article (PubMed ID: 23142309)
1. Can the Pelargonium sidoides root extract EPs® 7630 prevent asthma attacks during viral infections of the upper respiratory tract in children?
Tahan F; Yaman M
Phytomedicine; 2013 Jan; 20(2):148-50. PubMed ID: 23142309
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of Pelargonium sidoides in the treatment of upper respiratory tract infections in children with transient hypogammaglobulinemia of infancy.
Patiroglu T; Tunc A; Eke Gungor H; Unal E
Phytomedicine; 2012 Aug; 19(11):958-61. PubMed ID: 22809962
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
Lizogub VG; Riley DS; Heger M
Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
[TBL] [Abstract][Full Text] [Related]
4. Pelargonium sidoides extract for acute respiratory tract infections.
Timmer A; Günther J; Rücker G; Motschall E; Antes G; Kern WV
Cochrane Database Syst Rev; 2008 Jul; (3):CD006323. PubMed ID: 18646148
[TBL] [Abstract][Full Text] [Related]
5. Extract of Pelargonium sidoides (EPs 7630) inhibits the interactions of group A-streptococci and host epithelia in vitro.
Conrad A; Jung I; Tioua D; Lallemand C; Carrapatoso F; Engels I; Daschner FD; Frank U
Phytomedicine; 2007; 14 Suppl 6():52-9. PubMed ID: 17182236
[TBL] [Abstract][Full Text] [Related]
6. EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo.
Theisen LL; Muller CP
Antiviral Res; 2012 May; 94(2):147-56. PubMed ID: 22475498
[TBL] [Abstract][Full Text] [Related]
7. Pelargonium sidoides extract for treating acute respiratory tract infections.
Timmer A; Günther J; Motschall E; Rücker G; Antes G; Kern WV
Cochrane Database Syst Rev; 2013 Oct; (10):CD006323. PubMed ID: 24146345
[TBL] [Abstract][Full Text] [Related]
8. Pelargonium sidoides preparation (EPs 7630) in the treatment of acute bronchitis in adults and children.
Matthys H; Kamin W; Funk P; Heger M
Phytomedicine; 2007; 14 Suppl 6():69-73. PubMed ID: 17184981
[TBL] [Abstract][Full Text] [Related]
9. Extract of Pelargonium sidoides (EPs 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitro.
Conrad A; Hansmann C; Engels I; Daschner FD; Frank U
Phytomedicine; 2007; 14 Suppl 6():46-51. PubMed ID: 17184983
[TBL] [Abstract][Full Text] [Related]
10. Immune responses induced by Pelargonium sidoides extract in serum and nasal mucosa of athletes after exhaustive exercise: modulation of secretory IgA, IL-6 and IL-15.
Luna LA; Bachi AL; Novaes e Brito RR; Eid RG; Suguri VM; Oliveira PW; Gregorio LC; Vaisberg M
Phytomedicine; 2011 Feb; 18(4):303-8. PubMed ID: 20850953
[TBL] [Abstract][Full Text] [Related]
11. An extract of Pelargonium sidoides (EPs 7630) inhibits in situ adhesion of Helicobacter pylori to human stomach.
Wittschier N; Faller G; Hensel A
Phytomedicine; 2007 Apr; 14(4):285-8. PubMed ID: 17350240
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial.
Bereznoy VV; Riley DS; Wassmer G; Heger M
Altern Ther Health Med; 2003; 9(5):68-79. PubMed ID: 14526713
[TBL] [Abstract][Full Text] [Related]
13. Medicinal properties and conservation of Pelargonium sidoides DC.
Moyo M; Van Staden J
J Ethnopharmacol; 2014 Mar; 152(2):243-55. PubMed ID: 24463034
[TBL] [Abstract][Full Text] [Related]
14. Anti-infective activities of Pelargonium sidoides (EPS® 7630): effects of induced NO production on Leishmania major in infected macrophages and antiviral effects as assessed in a fibroblast-virus protection assay.
Thäle C; Kiderlen AF; Kolodziej H
Planta Med; 2011 May; 77(7):718-25. PubMed ID: 21104606
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an aqueous-ethanolic extract from Pelargonium sidoides (EPs® 7630) for its activity against group A-streptococci adhesion to human HEp-2 epithelial cells.
Janecki A; Conrad A; Engels I; Frank U; Kolodziej H
J Ethnopharmacol; 2011 Jan; 133(1):147-52. PubMed ID: 20883767
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides.
Matthys H; Lizogub VG; Malek FA; Kieser M
Curr Med Res Opin; 2010 Jun; 26(6):1413-22. PubMed ID: 20387996
[TBL] [Abstract][Full Text] [Related]
17. Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo.
Kolodziej H
Phytomedicine; 2007; 14 Suppl 6():9-17. PubMed ID: 17188477
[TBL] [Abstract][Full Text] [Related]
18. African geranium (EPs 7630), part I: a proprietary root extract of Pelargonium sidoides (EPs 7630) is found to be effective in resolving symptoms associated with the common cold in adults.
Ross SM
Holist Nurs Pract; 2012; 26(2):106-9. PubMed ID: 22343933
[No Abstract] [Full Text] [Related]
19. Evaluation of pharmacodynamic activities of EPs® 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis.
Bao Y; Gao Y; Koch E; Pan X; Jin Y; Cui X
Phytomedicine; 2015 Apr; 22(4):504-9. PubMed ID: 25925973
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs 7630.
Kolodziej H; Kiderlen AF
Phytomedicine; 2007; 14 Suppl 6():18-26. PubMed ID: 17188480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
